相关实验视频

Updated: Sep 16, 2025

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

G-四重复结构调节远程转录重编程,以促进卵巢癌细胞的耐药性

Jenna Robinson^1,2,3, Gem Flint^1,2, Ian Garner⁴

¹Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, 82 Wood Lane, London, W12 0BZ, UK.

|July 11, 2025

概括

基因组G四复合体 (G4s) 是药物耐药卵巢癌中关键的表观遗传调节体. 准G4s使抗化疗细胞重新敏感,为卵巢癌治疗提供了一个新的治疗策略.

科学领域:

表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.
基因组学就是基因组学.
癌症生物学癌症生物学

背景情况:

表观遗传改变驱使癌细胞逃避药物治疗,导致卵巢癌的死亡率.
DNA G四重复 (G4s) 正在成为癌症进化中的显著表观遗传标记.
对于卵巢癌药物耐药性的G4s的作用和分布仍然未被探索.

研究的目的:

研究G4s在抗药性卵巢癌细胞表观遗传调节中的作用.
将G4s在敏感和耐性卵巢癌细胞系中的全基因组分布映射出来.
探索针对卵巢癌中的G4s的治疗潜力.

主要方法:

在对配对的药物敏感和耐药卵巢癌细胞系中,全基因组映射G-四复合体 (G4s).
分析G4积累及其与药物耐药性途径的转录性变化之间的相关性.
在体外实验中使用小分子准G4s并评估它们对抗药细胞的影响.

主要成果:

增加的G4积累与药物耐药性途径的增强转录相关,包括上皮细胞-介质细胞过渡和WNT信号传递.
G4s调节跨基因和内基因区域的转录,促进耐药细胞的长距离转录控制.
G4集群 (超级G4s) 显示出强大的转录增强,超过超级增强剂;准G4s使细胞对化疗重新敏感.

结论:

G四重复结构是抗药性卵巢癌细胞内表观遗传调节网络的组成部分.
在卵巢癌中,G4s是克服药物耐药性的有希望的治疗标.
向G4s可以使抗化疗的卵巢癌细胞重新敏感,提供了一种新的治疗策略.

关键词:

在G-四重复合体中.卵巢癌是发生在卵巢中的癌症.电阻电阻电阻电阻电阻电阻转录转录转录转录

更多相关视频

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes

Single-Molecule Fluorescence Visualization of DNA Polymerase Dynamics at G-Quadruplexes

Published on: April 4, 2025

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

Combinatorial Gene Control

Combinatorial Gene Control

Combinatorial gene control is the synergistic action of several transcriptional factors to regulate the expression of a single gene. The absence of one or more of these factors may lead to a significant difference in the level of gene expression or repression.
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...

Eukaryotic Transcription Inhibitors

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...

RNA Polymerase II Accessory Proteins

RNA Polymerase II Accessory Proteins

Proteins that regulate transcription can do so either via direct contact with RNA Polymerase or through indirect interactions facilitated by adaptors, mediators, histone-modifying proteins, and nucleosome remodelers. Direct interactions to activate transcription is seen in bacteria as well as in some eukaryotic genes. In these cases, upstream activation sequences are adjacent to the promoters, and the activator proteins interact directly with the transcriptional machinery. For example, in...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...